ASTER DM QUALITY CARE LIMITED

BSE: ASTERDM540975ISIN INE914M01019

Healthcare
Hospital
BSE 500

BSE listing

Share price

₹755.85-4.55 (-0.60%)

as of 18 Sep 2026

52W high: ₹890.95
52W low: ₹519.80
Off 52W high: -15.16%
1M return: -5.60%
3M return: -6.57%
6M return: +20.50%
1Y return: +22.67%
20D avg volume: 2,46,372
50 DMA: ₹796.93
200 DMA: ₹703.60

Key ratios Consolidated

Market cap: ₹65,885 Cr
Current price: ₹755.85
52W high / low: ₹890.95 / ₹519.80
Face value: ₹10.00
P/E: 181.59
P/B: —
EPS (TTM): ₹4.16
Book value / share: —
ROE: —
ROCE: 10.20%
Operating margin: —
Net margin: —
Debt / equity: 0.15
Net debt: ₹473.11 Cr
Interest cover: 5.93
Dividend yield: 0.40%
Dividend / share (TTM): ₹3.00
Payout: 72.12%
Cash conversion cycle: -6.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	1,311	1,182	1,186	1,197	1,078	1,000	1,050	1,086	1,002	973.59	3,711	3,317
	37.03	36.20	27.97	28.25	33.18	31.28	32.99	35.24	48.72	4.08	7.95	8.59
	1,147	1,047	1,074	1,044	964.50	904.65	953.61	960.43	927.89	902.49	3,477	3,268
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	300.37	258.97	270.44	271.05	247.15	218.17	232.04	244.66	225.29	230.01	1,116	1,052
	242.20	219.99	221.37	211.92	194.81	182.96	193.64	193.35	190.44	170.89	1,162	1,130
	31.21	29.99	31.46	30.76	30.77	32.43	30.77	31.46	29.15	29.88	98.64	101.94
	69.29	67.24	67.67	66.12	63.22	63.95	62.21	62.27	60.41	58.36	231.54	227.16
	512.39	466.65	485.66	464.44	428.56	400.08	182.94	191.01	187.77	185.26	559.43	538.22
	200.85	171.55	140.09	181.21	146.55	126.97	129.19	161.25	122.70	75.18	241.91	56.76
	-114.38	0.33	-28.29	-0.36	-4.39	-26.42	-23.72	0.00	0.00	0.00	0.00	-54.62
	86.47	171.88	111.80	180.85	142.16	100.55	105.47	161.25	122.70	75.18	241.91	2.14
	48.80	9.77	44.40	45.54	42.88	5.00	37.49	52.89	38.99	30.57	24.24	10.17
	29.28	153.58	58.65	121.31	93.56	85.54	64.39	105.76	5,152	-2.17	209.22	-15.33
	0.31	2.72	1.02	2.13	1.67	1.59	1.14	1.94	1.49	0.66	3.60	-0.62
Key metrics
	186.97	269.11	210.93	277.73	236.15	196.93	198.45	254.98	212.26	163.42	572.09	331.24
	14.30%	22.80%	17.80%	23.20%	21.90%	19.70%	18.90%	23.50%	21.20%	16.80%	15.40%	10.00%
	2.20%	13.00%	4.90%	10.10%	8.70%	8.60%	6.10%	9.70%	514.30%	-0.20%	5.60%	-0.50%
	—	2.80%	—	3.10%	—	2.30%	—	—	—	—	—	—
	21.60%	18.20%	12.90%	10.20%	7.60%	2.70%	-71.70%	-67.20%	—	—	—	—
	-68.70%	79.50%	-8.90%	14.70%	-98.20%	4,041.90%	-69.20%	789.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	4,876	4,643	4,138	3,699	11,933	10,253	8,608	8,738	7,963	6,721
	129.45	125.60	148.23	24.85	78.25	50.66	49.97	37.87	34.62	45.44
	4,312	4,129	3,747	3,451	11,477	9,668	8,457	8,426	7,585	6,591
	0.00	0.00	0.00	—	—	—	—	—	—	—
	1,101	1,048	920.16	927.50	3,812	3,068	2,437	2,864	2,525	2,160
	895.48	848.09	760.39	675.93	3,965	3,264	2,755	2,904	2,688	2,271
	123.42	122.98	123.81	110.30	329.22	257.02	293.66	359.67	179.18	184.64
	270.32	264.25	248.84	219.97	780.44	640.58	617.57	585.94	306.47	297.74
	1,929	1,845	1,675	689.46	1,762	1,544	1,322	1,253	1,391	1,263
	693.70	639.40	540.11	272.53	533.86	636.31	201.53	349.87	412.02	175.83
	-142.70	-32.71	-50.14	0.00	0.00	0.00	0.00	-19.64	-1.52	129.64
	551.00	606.69	489.97	272.53	533.86	636.31	201.53	330.23	410.50	305.48
	148.51	142.59	134.37	56.51	59.59	35.80	27.22	15.38	42.94	26.08
	362.82	427.10	5,408	211.56	475.49	601.05	177.83	314.66	367.31	279.39
	6.18	7.53	107.98	3.60	8.55	10.58	2.97	5.51	6.63	—
Key metrics
	944.74	993.92	862.62	602.80	1,644	1,534	1,113	1,276	896.15	787.86
	19.38%	21.40%	20.80%	16.30%	13.80%	15.00%	12.90%	14.60%	11.30%	11.70%
	7.44%	9.20%	130.70%	5.70%	4.00%	5.90%	2.10%	3.60%	4.60%	4.20%
	—	10.20%	10.70%	—	—	—	—	—	—	—
	—	12.20%	11.90%	-69.00%	16.40%	19.10%	-1.50%	9.70%	18.50%	—
	—	-92.10%	2,456.20%	-55.50%	-20.90%	238.00%	-43.50%	-14.30%	31.50%	—
	—	186.84	79.01	—	—	—	—	—	—	—
	—	1.54	0.08	—	—	—	—	—	—	—
	—	0.15	0.18	—	—	—	—	—	—	—
	—	473.11	477.59	—	—	—	—	—	—	—
	—	-6.5	-6.8	—	—	—	—	—	—	—
Balance sheet
	—	8,112	6,606	—	—	—	—	—	—	—
	—	1,948	1,901	—	—	—	—	—	—	—
	—	228.07	164.59	—	—	—	—	—	—	—
	—	307.23	257.81	—	—	—	—	—	—	—
	—	91.16	92.35	—	—	—	—	—	—	—
	—	64.03	53.70	—	—	—	—	—	—	—
	—	2,619	3,628	—	—	—	—	—	—	—
	—	481.51	426.20	—	—	—	—	—	—	—
	—	979.16	879.21	—	—	—	—	—	—	—
	—	701.18	642.18	—	—	—	—	—	—	—
	—	142.74	158.47	—	—	—	—	—	—	—
	—	558.44	483.71	—	—	—	—	—	—	—
	—	4,834	3,651	—	—	—	—	—	—	—
Cash flow
	—	655.92	425.05	—	—	—	—	—	—	—
	—	-288.21	6,015	—	—	—	—	—	—	—
	—	-304.34	-6,358	—	—	—	—	—	—	—
	—	469.08	346.04	—	—	—	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	725.73	655.10	665.75	681.81	613.04	573.86	576.32	604.68	565.62	545.56	524.50	509.21
	39.03	40.55	31.41	44.64	38.43	35.13	37.29	46.74	5,620	3.72	13.33	20.48
	644.08	575.28	598.62	593.66	539.05	519.97	522.15	531.59	520.34	502.63	484.64	473.00
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	162.04	122.14	136.94	141.14	130.46	112.80	111.89	117.68	113.12	107.86	101.02	107.60
	121.39	103.94	105.10	102.93	91.48	86.06	96.06	96.75	96.22	77.85	84.75	83.43
	24.02	20.98	22.11	22.54	21.64	23.25	21.55	19.34	21.43	20.92	21.09	20.72
	41.32	37.57	39.45	39.12	37.88	37.76	35.55	36.57	34.64	35.65	30.55	29.13
	307.59	282.50	294.59	287.46	258.15	256.80	106.33	109.70	108.82	114.28	105.93	103.51
	120.68	120.37	98.54	132.79	112.42	89.02	91.46	119.83	5,665	46.65	53.19	56.69
	-109.79	-77.73	-7.44	-0.36	-4.39	-26.42	-23.13	—	372.70	—	—	—
	10.89	42.64	91.10	132.43	108.03	62.60	68.33	119.83	6,037	46.65	53.19	56.69
	25.19	15.18	35.94	27.82	27.44	1.53	18.51	29.99	29.25	54.76	—	2.37
	-14.30	27.46	55.16	104.61	80.59	61.07	49.82	89.84	6,008	-8.11	53.19	59.06
	-0.28	0.53	1.07	2.04	1.58	1.23	1.00	1.80	120.67	-0.16	1.07	1.19
Key metrics
	76.23	101.19	152.66	194.09	167.55	123.61	125.43	175.74	6,094	103.22	104.83	106.54
	10.50%	15.40%	22.90%	28.50%	27.30%	21.50%	21.80%	29.10%	1,077.30%	18.90%	20.00%	20.90%
	-2.00%	4.20%	8.30%	15.30%	13.10%	10.60%	8.60%	14.90%	1,062.20%	-1.50%	10.10%	11.60%
	—	1.10%	—	2.70%	—	1.90%	—	—	—	—	—	—
	18.40%	14.20%	15.50%	12.80%	8.40%	5.20%	9.90%	18.70%	—	—	—	—
	-117.70%	-55.00%	10.70%	16.40%	-98.70%	853.00%	-6.30%	52.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	2,728	2,616	2,320	2,036	1,534	1,116	746.54	760.42	594.78	530.07
	155.63	155.03	5,739	49.02	49.77	82.20	21.63	114.51	84.15	16.11
	2,412	2,307	2,094	1,876	1,401	1,109	836.21	810.32	628.89	633.37
	0.00	0.00	0.00	—	—	—	—	—	—	—
	562.26	530.68	455.49	418.10	336.63	277.64	181.66	194.57	145.55	—
	433.36	403.45	375.09	318.36	230.59	172.09	143.78	130.42	112.28	106.08
	89.65	87.27	85.57	78.37	51.81	44.02	36.50	33.20	10.86	53.95
	157.46	154.02	144.52	121.38	104.02	98.72	95.00	89.32	64.38	59.08
	1,172	1,123	1,032	410.69	293.84	227.36	169.33	180.81	147.92	132.04
	472.38	464.12	5,965	209.35	182.33	89.96	-68.04	64.61	50.04	-87.19
	-195.32	-89.92	323.15	—	—	—	—	—	-1.52	—
	277.06	374.20	6,288	209.35	182.33	89.96	-68.04	64.61	48.52	-87.19
	104.13	106.38	79.28	52.39	9.04	0.22	0.74	4.00	0.45	—
	172.93	267.82	6,209	156.96	173.29	90.18	-68.78	60.61	48.07	-87.19
	3.36	5.20	124.67	3.15	3.48	1.81	-1.38	1.21	0.96	—
Key metrics
	524.17	615.49	6,518	409.10	338.16	232.70	63.46	187.13	123.76	25.84
	19.21%	23.50%	280.90%	20.10%	22.00%	20.80%	8.50%	24.60%	20.80%	4.90%
	6.34%	10.20%	267.60%	7.70%	11.30%	8.10%	-9.20%	8.00%	8.10%	-16.40%
	—	8.10%	140.30%	—	—	—	—	—	—	—
	—	12.70%	13.90%	32.80%	37.40%	49.60%	-1.80%	27.80%	12.20%	—
	—	-95.70%	3,855.80%	-9.40%	92.20%	231.10%	-213.50%	26.10%	155.10%	—
	—	233.29	228.92	—	—	—	—	—	—	—
	—	1.45	0.06	—	—	—	—	—	—	—
	—	0.07	0.11	—	—	—	—	—	—	—
	—	194.24	257.54	—	—	—	—	—	—	—
	—	-11.2	-10.7	—	—	—	—	—	—	—
Balance sheet
	—	6,340	4,965	—	—	—	—	—	—	—
	—	1,511	1,612	—	—	—	—	—	—	—
	—	119.44	119.84	—	—	—	—	—	—	—
	—	178.94	138.13	—	—	—	—	—	—	—
	—	33.24	41.73	—	—	—	—	—	—	—
	—	33.63	25.08	—	—	—	—	—	—	—
	—	1,051	1,759	—	—	—	—	—	—	—
	—	292.34	247.91	—	—	—	—	—	—	—
	—	631.21	420.88	—	—	—	—	—	—	—
	—	313.68	377.38	—	—	—	—	—	—	—
	—	73.74	78.92	—	—	—	—	—	—	—
	—	239.94	298.46	—	—	—	—	—	—	—
	—	4,366	3,339	—	—	—	—	—	—	—
Cash flow
	—	387.13	367.23	—	—	—	—	—	—	—
	—	-143.59	6,023	—	—	—	—	—	—	—
	—	-243.94	-6,298	—	—	—	—	—	—	—
	—	153.84	138.31	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +19.48%
Sales CAGR 5Y: +28.50%
Sales CAGR 10Y: —
Profit CAGR 3Y: +15.62%
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): +15.22%
Profit YoY (TTM): -38.53%

Consolidated

Sales CAGR 3Y: -26.99%
Sales CAGR 5Y: -11.61%
Sales CAGR 10Y: —
Profit CAGR 3Y: -3.51%
Profit CAGR 5Y: +19.15%
Profit CAGR 10Y: —
Sales YoY (TTM): +15.70%
Profit YoY (TTM): +3.89%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 53.72%

Holder	Type	Holding	Previous	Change
Bcp Asia Ii Topco Iv Pte.Ltd.	Promoter	29.71%	—	—
Union Investments Private Limited	Promoter	21.44%	—	—
Centella Mauritius Holdings Limited	Public	9.90%	—	—
Hdfc Small Cap Fund	Public	5.19%	—	—
Rimco (Mauritius) Limited	Public	4.08%	—	—
Kotak Small Cap Fund	Public	2.84%	—	—
Union (Mauritius) Holdings Limited	Promoter Group	2.29%	—	—
Sbi Contra Fund	Public	1.62%	—	—
Quant Mutual Fund - Quant Small Cap Fund	Public	1.35%	—	—
Rashid Aslam Bin Mohideen Mammu Haji	Public	1.29%	—	—
M I Sahadulla	Public	1.21%	—	—
Smallcap World Fund, Inc	Public	1.15%	—	—
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund	Public	1.05%	—	—
Azad Moopen Mandayapurath	Promoter	0.17%	—	—
Naseera Azad	Promoter Group	0.03%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Please find enclosed an Addendum to the Notice of the 18th Annual General Meeting of the Company19 Sep 2026 · Company Update / General
Revision in Credit Rating of a Material Subsidiary16 Sep 2026 · Company Update / Credit Rating
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd10 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September ....9 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Union (Mauritius) Holdings Ltd9 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Dispatch of Notice of 18th Annual General Meeting and Integrated Annual Report for the financial year 2025-265 Sep 2026 · Company Update / Newspaper Publication
Business Responsibility and Sustainability Report for the financial year 2025-265 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report for FY 2025-265 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of the 18th Annual General Meeting4 Sep 2026 · AGM/EGM / AGM
Press Release - Dr. Moopen family picks up additional stake in the Company4 Sep 2026 · Company Update / Press Release / Media Release
Newspaper publication regarding intimation of 18th Annual General Meeting scheduled to be held on 28 September 20262 Sep 2026 · Company Update / Newspaper Publication
Intimation regarding capacity expansion at facility of a material subsidiary of the Company31 Aug 2026 · Company Update / General
Intimation of Scheme of Amalgamation of step down subsidiaries of the Company29 Aug 2026 · Company Update / Restructuring
Acquisition of Equity Shares of STS Holdings Limited by a Subsidiary of the Company28 Aug 2026 · Company Update / Acquisition
Newspaper advertisement regarding dispatch of the Notice of Postal Ballot of the Company27 Aug 2026 · Company Update / Newspaper Publication
Notice of Postal Ballot seeking approval of shareholders26 Aug 2026 · AGM/EGM / Postal Ballot
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB Trustee (Hong Kong) Ltd26 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....26 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 26, 2026 for Union (Mauritius) Holdings Ltd26 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GLAS Trust (Singapore) Ltd25 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG22 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....22 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 21, 2026 for BCP Asia II Topco IV Pte Ltd22 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GLAS Trust (Singapore) Ltd21 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Centella Mauritius Holdings Ltd21 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Centella Mauritius Holdings Ltd21 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd21 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd20 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Intimation regarding receipt of trading approval for equity shares allotted in terms of Scheme of Amalgamation14 Aug 2026 · Company Update / General
Transcript of earning conference call held for the quarter ended 30 June 202612 Aug 2026 · Company Update / Earnings Call Transcript
Newspaper publication regarding unaudited financial results for the quarter ended 30 June 20266 Aug 2026 · Company Update / Newspaper Publication
Video/Audio Recording of Earnings Call for the quarter ended 30 June 20265 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation that the Company will be participating in the Non-deal Roadshow organized by Kotak Mahindra Capital Company Limited from 10 August 2026 to 14 August 20265 Aug 2026 · Company Update / Analyst / Investor Meet
Acquisition of equity shares of United CIIGMA Institute of Medical Sciences, a Subsidiary Company of the Company5 Aug 2026 · Company Update / Acquisition
Approval of Notice of 18th AGM and Postal Ballot and other required disclosures5 Aug 2026 · Company Update / General
Press release in relation to unaudited financial results for the quarter ended 30 June 20265 Aug 2026 · Company Update / Press Release / Media Release
Investor presentation for earnings conference call with analysts/ institutional investors scheduled for 5 August 20265 Aug 2026 · Company Update / Investor Presentation
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 20265 Aug 2026 · Result / Financial Results
Outcome of the Board Meeting - Unaudited Financial Results (standalone and consolidated) for the first quarter ended 30 June 20265 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation of schedule of Analyst/Investors call for Quarter ended 30 June 202631 Jul 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Interim Dividend - Rs. - 3.0000	2 Apr 2026	3 Apr 2026	—
Final Dividend - Rs. - 1.0000	28 Aug 2025	28 Aug 2025	—
Interim Dividend - Rs. - 4.0000	10 Feb 2025	10 Feb 2025	—
Final Dividend - Rs. - 2.0000	22 Aug 2024	22 Aug 2024	—

Board meetings

5 Aug 2026 Board Meeting - Financial Results